SIRT1 and cancer: We report here a new SIRT1 inhibitor JQ-101, a compound possessing a polyprenylated acylphloroglucinol (PPAP) core, which exhibits selective inhibition of tumor cell line growth and survival though induction of apoptosis and cellular senescence, and significantly suppresses cancer cell invasion.